These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8870724)

  • 1. Evaluating treatment for visceral leishmaniosis.
    Vercammen F
    J Am Vet Med Assoc; 1996 Oct; 209(8):1379. PubMed ID: 8870724
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of allopurinol to treat visceral leishmaniosis in a dog.
    Lester SJ; Kenyon JE
    J Am Vet Med Assoc; 1996 Aug; 209(3):615-7. PubMed ID: 8755981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of autochthonous canine leishmaniasis in The Netherlands.
    Díaz-Espiñeira MM; Slappendel RJ
    Vet Q; 1997 Jun; 19(2):69-71. PubMed ID: 9225436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol in the treatment of canine visceral leishmaniasis.
    Liste F; Gascon M
    Vet Rec; 1995 Jul; 137(1):23-4. PubMed ID: 7483228
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of canine visceral leishmaniasis with allopurinol.
    Vercammen F; De Deken R
    Vet Rec; 1995 Sep; 137(10):252. PubMed ID: 8533220
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical follow-up examination after treatment of canine leishmaniasis.
    Moritz A; Steuber S; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
    Rougier S; Vouldoukis I; Fournel S; Pérès S; Woehrlé F
    Vet Parasitol; 2008 May; 153(3-4):244-54. PubMed ID: 18337012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR follow-up examination after treatment of canine leishmaniosis (CaL).
    Steuber S; Moritz A; Schirrmann I; Greiner M
    Tokai J Exp Clin Med; 1998 Dec; 23(6):285-92. PubMed ID: 10622624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Fidan Yaylali G; Yalcin Colakoglu N; Yilmaz M
    Scand J Infect Dis; 2006; 38(3):208-10. PubMed ID: 16500783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Yaylali GF; Colakoglu NY; Yilmaz M
    Scand J Infect Dis; 2006; 38(2):152-4. PubMed ID: 16449014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular lesions of the tongue in canine leishmaniosis.
    Parpaglia ML; Vercelli A; Cocco R; Zobba R; Manunta ML
    J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):414-7. PubMed ID: 17877582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
    Segarra S; Miró G; Montoya A; Pardo-Marín L; Boqué N; Ferrer L; Cerón J
    Vet Parasitol; 2017 May; 239():50-56. PubMed ID: 28495197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-phase proteins in dogs naturally infected with Leishmania infantum during and after long-term therapy with allopurinol.
    Sasanelli M; Paradies P; de Caprariis D; Greco B; De Palo P; Palmisano D; Carelli G
    Vet Res Commun; 2007 Aug; 31 Suppl 1():335-8. PubMed ID: 17682908
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leishmaniasis in dogs in Germany: epidemiological case analysis and alternatives to conventional causal therapy].
    Gothe R; Nolte I; Kraft W
    Tierarztl Prax; 1997 Jan; 25(1):68-73. PubMed ID: 9157633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allopurinol therapy in imported dogs with leishmaniasis treated outside the endemic area].
    Helm M; Müller W; Schaarschmidt D; Grimm F; Deplazes P
    Schweiz Arch Tierheilkd; 2013 Oct; 155(10):559-67. PubMed ID: 24091231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum in a Central Italy dog shelter: retrospective study of serologic reactivity during a 4-year period in a confined dog population subjected to preventive and therapeutic treatment.
    Podaliri Vulpiani M; Iannetti L; Di Mattia T; Dalla Villa P
    Vet Parasitol; 2009 Mar; 160(3-4):190-7. PubMed ID: 19111991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in the endemic areas.
    Saridomichelakis MN; Mylonakis ME; Leontides LS; Billinis C; Koutinas AF; Galatos AD; Gouletsou P; Diakou A; Kontos VI
    Vet Parasitol; 2005 Jun; 130(3-4):199-205. PubMed ID: 15905034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.